Does HRT cause cancer? The short answer
For most women, HRT does not cause cancer in any simple, direct way. Hormone replacement therapy nudges the risk of a few cancers up, pushes the risk of others down, and leaves several unchanged, and the size of any change depends on the type of HRT, how long you use it, and your own baseline risk. The most consistent link is a small rise in breast cancer among women who take combined estrogen plus progestogen for several years. Estrogen-only HRT behaves very differently, and in one large trial it was tied to slightly fewer breast cancers rather than more.
That nuance is the whole story. The question "does hormone therapy cause cancer" has no single yes-or-no answer, because the answer changes with the cancer type and the regimen. Below is what the evidence actually shows for breast, uterine, ovarian, and bowel cancer, with the numbers in plain terms.
How HRT and cancer risk are linked
Estrogen tells certain tissues to grow, including the lining of the uterus and some breast cells. That's why the cancers most affected by HRT are hormone-sensitive ones. Two design choices drive almost all of the risk picture:
- Estrogen-only vs combined. Women who still have a uterus need a progestogen alongside estrogen to protect the womb lining. Women who've had a hysterectomy usually take estrogen alone. These two regimens have genuinely different cancer profiles.
- Duration. Short-term use for menopausal symptoms carries a much smaller signal than a decade or more of continuous use. Risk also fades over the years after you stop.
The forms HRT comes in (patch, gel, tablet, spray) matter more for blood clot and stroke risk than for cancer. For a wider look at the trade-offs, our overview of HRT benefits and side effects sets the cancer question in context with the heart, bone, and mood effects that usually weigh in the other direction.
HRT and breast cancer
This is the risk most people are actually asking about. Here's the honest version.
Combined HRT (estrogen plus a progestogen) is linked to a small increase in breast cancer that grows the longer you take it. Pooled data summarized by Cancer Research UK and the National Cancer Institute point to roughly one extra breast cancer per 50 women who use combined HRT for about five years starting around age 50, counted over the following two decades. Estrogen-only HRT carries a much smaller signal, on the order of one extra case per 200 women over the same window, and the Women's Health Initiative estrogen-only arm actually reported slightly fewer breast cancers in users than non-users.
A few points that get lost in headlines:
- The excess risk shrinks after you stop, though some of it can persist for more than a decade with long combined use.
- Being overweight, drinking alcohol regularly, and lack of activity each raise breast cancer risk by amounts in the same ballpark as a few years of HRT.
- Micronized (body-identical) progesterone may carry a smaller breast cancer signal than older synthetic progestins in observational studies, though the evidence isn't settled enough to call it risk-free.
HRT breast cancer risk chart
| HRT type | Direction of breast cancer risk | Rough absolute effect |
|---|---|---|
| Estrogen-only (no uterus) | Flat, possibly slightly lower | About 1 fewer to no extra case per 200 over 20 years |
| Combined, under 5 years | Small increase | Modest, hard to measure precisely |
| Combined, around 5 years | Clear small increase | About 1 extra case per 50 over 20 years |
| Combined, 10+ years | Larger increase | Risk keeps climbing with duration |
| Vaginal (local) estrogen | No meaningful change | Not linked to higher breast cancer risk |
Putting the breast cancer numbers in context
A relative number like "20 percent higher" sounds alarming until you anchor it to your starting point. If you want your personal baseline, the NCI Breast Cancer Risk Assessment Tool (the Gail model) estimates five-year and lifetime risk from your age, family history, and other factors. A breast cancer risk calculator won't tell you whether to take HRT, but it shows whether a small relative bump lands on a low or a high base, which is the figure your doctor weighs.
Does estradiol cause cancer?
Estradiol is the main estrogen used in modern HRT, and on its own it is the part that can stimulate the uterine lining. Taken without a progestogen by a woman who still has her uterus, estradiol raises the risk of endometrial (uterine) cancer, and that risk climbs steeply with years of unopposed use. This is exactly why a progestogen is prescribed alongside it. With continuous combined HRT, endometrial cancer risk is not raised, and may even drop slightly.
So "does estradiol cause cancer" depends entirely on whether it's balanced. Estradiol plus adequate progestogen protects the womb. Estradiol alone, in someone with a uterus, does not. Low-dose vaginal estradiol used for dryness delivers very little hormone to the rest of the body and has not been shown to meaningfully raise cancer risk.
One warning sign is worth knowing: unexpected bleeding after menopause, or new bleeding on a continuous regimen, can occasionally flag an endometrial problem and should always be checked. Our guide to what causes bleeding on HRT explains which patterns are routine and which ones mean you should call your clinician promptly.
HRT and ovarian cancer
Both estrogen-only and combined HRT are tied to a small increase in ovarian cancer. The most-cited pooled analysis found roughly one extra ovarian cancer per 1,000 women using HRT for about five years, an effect that appears soon after starting and fades after stopping. Ovarian cancer is uncommon to begin with, so the absolute number of extra cases is small, but it's a real and consistent finding rather than a fluke.
HRT and colon cancer
Here the news runs the other way. In the Women's Health Initiative, women on combined HRT had a lower rate of colorectal cancer than those on placebo, a reduction of roughly a third. Estrogen-only therapy showed no clear effect. Nobody recommends starting HRT to prevent bowel cancer, partly because cancers that did occur in the combined group tended to be found at a later stage, but it's a fair counterweight when people assume HRT raises every cancer risk.
Cancer risk at a glance
| Cancer type | Estrogen-only HRT | Combined HRT |
|---|---|---|
| Breast | Flat or slightly lower | Small increase, grows with duration |
| Endometrial (uterine) | Increased if used without a progestogen | No increase, slight decrease |
| Ovarian | Small increase | Small increase |
| Colorectal (colon) | No clear change | Reduced risk |
Who should be more cautious
HRT isn't a flat yes or no for everyone. Talk through the risks carefully if you have a personal history of breast or endometrial cancer, a known high-risk gene such as BRCA1 or BRCA2, a strong family history of hormone-sensitive cancer, or unexplained vaginal bleeding that hasn't been investigated. The "timing" matters too: starting HRT before age 60 or within 10 years of your last period generally has a more favorable benefit-to-risk balance than starting much later. None of this rules HRT out, but it shifts the conversation toward lower doses, estrogen-only where appropriate, or non-hormonal options.
What to do next
If symptoms are disrupting your sleep, mood, or daily life, the cancer risk from a few years of HRT is usually small and, for breast cancer, comparable to everyday factors like alcohol and weight. Bring your own history to the appointment: ask whether estrogen-only is an option, whether body-identical progesterone suits you, and what the lowest effective dose looks like. Keep up routine mammograms and report any new bleeding. The goal is a plan that treats your symptoms while keeping your individual risk as low as it can reasonably go.
Frequently Asked Questions
Does HRT cause breast cancer for everyone who takes it?
No. Combined HRT raises breast cancer risk by a small amount that increases with years of use, while estrogen-only HRT shows little or no increase and in one major trial was linked to slightly fewer cases. Most short-term users see only a minor change to their baseline risk.
Is there an HRT type that's safer for cancer risk?
Estrogen-only therapy (for women without a uterus) and low-dose vaginal estrogen carry the smallest cancer signals. Among combined regimens, body-identical micronized progesterone may be gentler on breast risk than older synthetic progestins, though the evidence isn't conclusive.
How long after stopping HRT does cancer risk go back to normal?
Ovarian and most breast cancer risk falls in the years after you stop, but with long-term combined HRT some excess breast cancer risk can linger for a decade or more. Shorter use clears faster.
Does HRT cause uterine or ovarian cancer?
Estrogen without a progestogen raises uterine cancer risk in women who still have a uterus, which is why the two are prescribed together. Both HRT types add a small increase in ovarian cancer, around one extra case per 1,000 users over five years.
Can I take HRT if I've already had breast cancer?
Usually systemic HRT is avoided after a hormone-sensitive breast cancer, and non-hormonal treatments are tried first. This is a decision to make with your oncologist, since it depends on the cancer type and your symptoms.